Skip to main content

Table 4 Secondary outcomes

From: The MOVE-trial: Monocryl® vs. Vicryl Rapide™ for skin repair in mediolateral episiotomies: a randomized controlled trial

 

Monocryl (n = 64)

Vicryl rapide (n = 67)

p-value

Analgesia use 24 h

22 (34%)

29 (43%)

0.30

Dehiscence 24 h

0 (0%)

1 (1%)

0.51

Analgesia use 10 days

5 (8%)

10 (15%)

0.20

Dehiscence 10 days

5 (8%)

15 (22%)

0.02

Infection 10 days

4 (6%)

2 (3%)

0.32

Removal of stitches 10 days

3 (5%)

8 (12%)

0.14

Intercourse 6 weeks

27 (42%)

29 (43%)

0.96

Painless intercourse 6 weeks

12 (19%)

11 (16%)

0.75

Intercourse 3 months

52 (81%)

52 (78%)

0.61

Painless intercourse 3 months

32 (50%)

39 (58%)

0.50

Dehiscence within 3 months

6 (10%)

17 (25%)

0.016

Stitches removal within 3 months

9 (11%)

8 (12%)

0.72

Infection within 3 months

4 (7%)

2 (3%)

0.37

  1. Variables are given as frequencies with percentages, n (%) and p-values